Drug Discovery · Watertown, MA · Founded 2019 · Privately Held (backing)
Developer of a clinical-stage biotechnology company designed to create antibody-based therapies targeting immunological and inflammatory diseases. Triveni Bio is based in Watertown, MA and was founded in 2019. It is valued at about $398 million as of Oct 2026, set by institutional fund marks, up 28% since its later-stage round in Jun 2025. It has raised $232 million across 2 recorded rounds; the latest was an $115 million Series B in Jun 2025.
PMV mark · valuation
$398.1M
Oct 2026
Since last round
+28%
Jun 2025
Total raised
$231.6M
Last round
Later Stage VC (Series B)
Jun 2025
Team — not yet on record
No current team members for Triveni Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Triveni Bio with a free account
·The complete investor list: 12 names
·Watch Triveni Bio: the Monday email on marks, rounds and moves
